Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-04-30

Clinical Trial Update: Biofeedback for Adolescent Cannabis Use Disorder [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 trial evaluating biofeedback for adolescent cannabis use disorder has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Denver Health and Hospital Authority | Conditions: Adolescent Cannabis Use Disorder | Phase 1, Phase 2 | Status: WITHDRAWN